Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Hu, Ji-Fan  [Clear All Filters]
Journal Article
Liu MM, Ji W, Zhao X, Liu X, Hu J-F, Cui J. Therapeutic potential of engineering the mitochondrial genome. Biochim Biophys Acta Mol Basis Dis. 2023:166804.
Wang W, Zhou L, Li H, Sun T, Wen X, Li W, Esteban MA, Hoffman AR, Hu J-F, Cui J. Profiling the role of m6A effectors in the regulation of pluripotent reprogramming. Hum Genomics. 2024;18(1):33.
Sun J, Hu RP, Han M, Tan Y, Xie M, Gao S, Hu J-F. Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia. Int J Biol Sci. 2024;20(1):175-181.
Li X, Chen N, Zhou L, Wang C, Wen X, Jia L, Cui J, Hoffman AR, Hu J-F, Li W. Erratum: Genome-wide target interactome profiling reveals a novel epigenetic pathway for oncogenic lncRNA in breast cancer. Am J Cancer Res. 2023;13(9):4490-4491.
Zhang Y, Hu J-F, Wang H, Cui J, Gao S, Hoffman AR, Li W. CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors. Oncotarget. 2016.
Zhu X, Pan X, Yao L, Li W, Cui J, Wang G, Mrsny RJ, Hoffman AR, Hu J-F. Converting Skin Fibroblasts Into Hepatic-Like Cells by Transient Programming. J Cell Biochem. 2015.
Du Z, Jia L, Wang Y, Wang C, Wen X, Chen J, Zhu Y, Yu D, Zhou L, Chen N, et al. Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming. Sci Data. 2018;5:180255.